See the DrugPatentWatch profile for linzess
Linzess, a medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC), is expected to face generic competition in the coming years.
When does Linzess patent expire?
The primary patents protecting Linzess are set to expire in the mid-2020s. Specifically, key patents are listed as expiring around 2026 and 2027 [1]. However, patent expiry dates can be complex due to various factors, including additional patent filings and potential litigation.
Can generic Linzess be available before patent expiry?
In some cases, generic versions of a drug can become available before the main patent's expiration through patent challenges or settlements with the patent holder. These processes can be lengthy and depend on specific legal outcomes. DrugPatentWatch.com tracks these developments [1].
What is the active ingredient in Linzess?
The active ingredient in Linzess is linaclotide [2]. It works by increasing fluid secretion in the intestines, which helps to move stool through the digestive tract [3].
Who manufactures Linzess?
Linzess is jointly developed and marketed by AbbVie and Ironwood Pharmaceuticals [2].
How does Linzess work?
Linaclotide is a guanylate cyclase-C (GC-C) agonist. By activating GC-C in the intestinal epithelium, it increases the secretion of chloride and bicarbonate into the lumen, which leads to increased intestinal fluid and transit [3].
What are the risks associated with Linzess?
The most common side effect of Linzess is diarrhea [3]. Severe diarrhea can lead to serious complications such as dehydration [3]. Patients are advised to inform their doctor if they experience severe diarrhea or other concerning symptoms.
What other treatments are available for IBS-C and CIC?
Besides Linzess, other treatments for IBS-C and CIC include dietary changes, lifestyle modifications, and other medications like lubiprostone, plecanatide, and prucalopride, depending on the specific condition and patient needs [4].
How will generic Linzess affect pricing?
Historically, the introduction of generic versions of a drug leads to a significant decrease in its price. This can make the medication more accessible to patients and healthcare systems.
Sources:
[1] DrugPatentWatch.com: https://www.drugpatentwatch.com/
[2] AbbVie Inc. and Ironwood Pharmaceuticals Inc. (Press Releases and Company Information)
[3] U.S. Food and Drug Administration (FDA) Labeling Information for Linzess
[4] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Information on IBS and Constipation